-- Two expert-led Allergan Medical Institute
(AMI) symposia will explore a personalized approach to aesthetics,
featuring live injection sessions with Dr Mauricio De Maio, Dr Mansi Mukherjee and Dr
Steven Liew --
-- World class experts to convene on socially
transformative aesthetic medicine at Science of AgingTM
event --
-- Seventeen posters exhibiting new
clinical data on toxins and fillers showcase the diverse Allergan
Aesthetics portfolio --
-- Allergan Aesthetics' innovative discovery
booth explores what it means to be a True Original --
IRVINE,
Calif., March 21, 2024 /PRNewswire/ -- Allergan
Aesthetics demonstrates its ongoing commitment to originality and
its bold approach to aesthetics at the Anti-Aging and Aesthetics
Medicine World Congress (AMWC) in Monaco from Wednesday, March 27– Friday, March 29, 2024. Events include two
Allergan Medical Institute (AMI) symposia, Science of
AgingTM event, Meet the Expert
presentations, poster sessions and an interactive exhibition
booth.
"AMWC presents an invaluable opportunity to meet with esteemed
experts from across the globe," said Carrie
Strom, President, Global Allergan Aesthetics. "Through our
expert-led AMI symposia and series of thought-provoking events,
we're showcasing our innovative approach to aesthetics with an
emphasis on thoughtful consultation with our diverse and expanding
product portfolio to further shape the future of the industry."
As industry pioneers, Allergan Aesthetics has been at the
forefront of uncovering the trends that are shaping aesthetics.
Activities taking place at AMWC this year further showcase Allergan
Aesthetics timeless approach as it goes beyond the trends with
decisive and thoughtful action. Centering around its True Originals
theme, Individuality, Innovation and Integrity, Allergan Aesthetics
is shaping the future of the aesthetics industry.
AMWC 2024 AMI symposia
The first symposium, 'True
Originals: A Personalised Approach with the Allergan Aesthetics
Range', focuses on an in-depth look into patient needs. The
symposium will be co-chaired by Dr. Sophie
Shotter (UK) and cosmetic dermatologist Dr. Andre Braz
(Brazil), with expert panel
discussions and two live injector sessions from Dr. Mansi Mukherjee
(UAE) and Dr. Steven Liew
(Australia).
The second day opens with an introduction to the future of
individuality from Carrie Strom,
President, Global Allergan Aesthetics, Dr. Tapan Patel (UK) and Dr. Juliana Chieppe
(Brazil) and leads to the
symposium 'True Originals: Decoding the Future of Aesthetic
Individuality'. During the session, they will dive deeper into
the exclusive report and discuss trends, techniques, and drivers
for personalized treatment around the world. To end the day,
renowned plastic surgeon Dr. Mauricio de
Maio (Brazil) will perform
a live injection on stage.
The symposia will take place as follows:
- True Originals: A Personalised Approach with the Allergan
Aesthetics Range. 11.15 AM –
1:15 PM on Wednesday, March 27 in the
Salle des Princes, Grimaldi
Forum
- True Originals: Decoding the Future of Aesthetic
Individuality. 9:45 AM– 12:45 PM on
Thursday, March 28 in the Salle des Princes, Grimaldi Forum.
Beyond the AMI symposia
Dr. Steven Dayan will chair the Global Aesthetics
Medical Affairs symposia, presenting 'Socially
Transformative Aesthetic Medicine' alongside Dr. Mitchell Brin (US), Dr. Izolda Heydenrych (South Africa) and Damon Caiazza (US). Key topics include bias,
emotional impact, social perception and future innovation.
Dr. Stephanie Manson Brown, Vice
President, Head of Clinical Development and Scientific Innovation
at Allergan Aesthetics, will open the exclusive
thought-provoking Science of
AgingTM symposia event,
where world-class experts Dr Saranya
Wyles (US), Professor Claire
Stewart (UK), Professor Gordan
Lauc (Croatia) and Dr
Janine Sengstack (US) will present
the latest early science and research insights in the field of
aging. Key topics include cellular aging and rejuvenation, exosomes
and glyconology. The session will conclude with a Q&A session
led by event chair Dr. Patricia
Ogilvie (Germany).
The symposia will take place as follows:
- Global Aesthetics Medical Affairs Symposium.
2:00 PM – 4:00
PM on Wednesday, March 27 in the Genevoix Room, Grimaldi
Forum
- Science of AgingTM
Symposium. 4:30 PM –
6:30 PM on Wednesday, March 27 in the
Auric Room, Grimaldi Forum.
Meet the Experts
Allergan Aesthetics will host a
series of Meet the Experts sessions live from the booth,
featuring:
- Combination treatment for male patients with Dr.
Sebastien Derieux, France.
- The importance of facial shape in Asian beauty with Dr.
Jialun Li, China.
- Juvéderm® VOLUMA® and VOLUX™ for the
lower face – Drivers for Choice with Dr. Emily Schultz, Canada.
- Combination treatment of Hyaluronic acid injection and
Cryolipolysis for Lower face contouring with Dr. Kumiko Shimojima, Japan.
- From Simple to Regal – Transformation with the Full Allergan
Aesthetics Portfolio with Dr. Silvia
Ramirez, Singapore.
Aesthetics-Ethics
AMWC 2024 marks the launch of Moving the Needle on
Ethics, a collaboration with medical aesthetics experts from
around the globe with the aim of igniting thoughtful conversations
on the importance of ethics in aesthetics medicine. This initiative
is a result of Allergan Aesthetics' extensive global research on
ethics, which includes global social media listening, insight
gathering and face-to-face discussions across the industry in 13
countries.1
Visit the global Allergan Aesthetics website to download the
'Moving the Needle on Ethics' book and discover how
Allergan Aesthetics is spotlighting future industry priorities in
collaboration with leading experts. The 'Moving the Needle on
Ethics' short film will be available to watch from the
booth.
Allergan Aesthetics booth
Attendees can explore
interactive areas of the booth K2 (Ravel Floor) to learn more about
Allergan Aesthetics' commitment to maintaining its True Original
status, and actions it's taking to empower excellence and lead
innovation in aesthetics.
New clinical data on toxins and fillers
Allergan
Aesthetics' commitment to advancing clinical data and evidence is
demonstrated with the acceptance of 17 poster presentations to this
year's congress. Posters have been accepted across various
products, treatments and indications. For poster details please see
Notes to Editors below.
Be a True Original with Allergan Aesthetics.
Visit the symposia and exhibition booth K2, Ravel Floor in
the Grimaldi Forum to discover more.
About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop,
manufacture, and market a portfolio of leading aesthetics brands
and products. Our aesthetics portfolio includes facial injectables,
body contouring, plastics, skin care, and more. Our goal is to
consistently provide our customers with innovation, education,
exceptional service, and a commitment to excellence, all with a
personal touch. For more information, visit
www.allerganaesthetics.com
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
and solutions that solve serious health issues today and address
the medical challenges of tomorrow. We strive to have a remarkable
impact on people's lives across several key therapeutic areas –
immunology, oncology, neuroscience, and eye care – and products and
services in our Allergan Aesthetics portfolio. For more information
about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on
LinkedIn, Facebook, Instagram, X (formerly Twitter), and
YouTube.
Forward-Looking Statements
Some statements in this news release are, or may be
considered, forward-looking statements for purposes of the Private
Securities Litigation Reform Act of 1995. The words "believe,"
"expect," "anticipate," "project" and similar expressions and uses
of future or conditional verbs, generally identify forward-looking
statements. AbbVie cautions that these forward-looking statements
are subject to risks and uncertainties that may cause actual
results to differ materially from those expressed or implied in the
forward-looking statements. Such risks and uncertainties include,
but are not limited to, challenges to intellectual property,
competition from other products, difficulties inherent in the
research and development process, adverse litigation or government
action, and changes to laws and regulations applicable to our
industry. Additional information about the economic, competitive,
governmental, technological and other factors that may affect
AbbVie's operations is set forth in Item 1A, "Risk Factors," of
AbbVie's 2022 Annual Report on Form 10-K, which has been filed with
the Securities and Exchange Commission, as updated by its
subsequent Quarterly Reports on Form 10-Q. AbbVie undertakes no
obligation, and specifically declines, to release publicly any
revisions to forward-looking statements as a result of subsequent
events or developments, except as required by law.
Notes to Editors
Please find titles and named
authors for the 17 posters to be showcased at AMWC 2024 included
below:
- OnabotulinumtoxinA Efficacy and Safety in the Treatment of
Masseter Muscle Prominence: 6-Month Results From a Phase
3, Randomized, Placebo-Controlled, Multiregional Study. Authors:
Jiaming Sun, Yan Wu, Shyi-Gen Chen, Shannon Humphrey, Steven
Liew, Joan-En Chang-Lin, Lijuan
Zhang, Grace Pan,
Elisabeth Lee
- Patient-Reported Outcomes with Repeat Administration(s) of
OnabotulinumtoxinA for the Treatment of Masseter Muscle
Prominence: Results From a Phase 3 Multiregional Study.
Authors: Shu-Hung Huang,
William McGillivray, Yan Wu, Yuguang
Zhan, Donna Faletto,
Grace Pan, Catherine Foley, Vaishali Patel
- Patient-Reported Outcomes From OnabotulinumtoxinA
Treatment for Masseter Muscle Prominence: 6-Month Results From
a Phase 3, Randomized, Placebo-Controlled, Multiregional Trial.
Authors: Yuguang Zhang, William McGillivray, Shu
Hung Huang, Donna Faletto,
Grace Pan, Catherine Foley
- Treating Platysma Prominence with
OnabotulinumtoxinA: Efficacy and Safety Results from a
Phase 3 Multicenter, Randomized, Double-blind, Placebo-Controlled
Study. Authors: Sabrina Fabi, MD;
Brian Biesman, MD, Rosalyn George, MD, Shannon Humphrey, MD, Brenda LaTowsky, MD; Robert Weiss, MD, Grace
S. Park, DrPH, Warren Tong,
PharmD, Elisabeth Lee, MBA, MPH,
René Hopfinger, MS
- Safety and Efficacy of Multiple
Simultaneous Cryolipolysis Treatments Using a Dual Applicator
Cryolipolysis System. Authors: Amir
Moradi, M.D.; Grant Stevens,
M.D.; Felicia Tsai, MA; Rafael
Ostrowski, BS; Sylvia Gamio,
MSc; Eric Bachelor, M.D
- Towards a Mechanism of Action of Skin Changes
after Cryolipolysis. Authors: Joel
Jimenez Lozano, PhD
- Prospective, Multi-Country, Post-Marketing Study with Novel
Dual-Applicator Cryolipolysis System Demonstrates High
Participant Satisfaction, Safety and Effectiveness at 4 Weeks Post
Initial Treatment and 12 Weeks Post Final Treatment Session.
Authors: Jens Altmann, MD; Ulf
Samuelson, MD; Sabrina Fabi,
MD; Mitchel P. Goldman, MD;
Suzanne Kilmer, MD; Jean Michel Mazer, MD; Roy Geronemus, MD; Terence Tan, MBBS, MRCS, MMed; Jordan Wang, MD, MBE, MBA; Yi Li; Alda
Karic, PharmD
- A prospective, open-label, post-marketing study of the
safety and effectiveness of HArmonyCa injectable gel for
midface soft tissue augmentation: Interim
analysis. Authors: Graeme
Kerson, Alesandro Gritti,
Malka Salomon, Andrew Schumacher
- Restoration of Jawline Definition in Males with
Hyaluronic Acid Injectable Gel VYC-25L: Results from a Pivotal,
Multicenter, Randomized Controlled Trial. Authors:
Terrence Keaney, MD, FAAD;
Raza Ahmed, MD; Elena Dimitrijevic, PhD; Alexander Rivkin, MD
- An Evaluation of VYC-17.5L for Forehead Contouring: A
Prospective, Open-Label, Post-Marketing Study. Authors:
Nicola Kefalas, Sofia Ruiz Del Cueto, Carola De La Guardia, Graeme Kerson, Fernando
Urdiales Galvez, Alessandro
Gritti
- An Evaluation of VYC-17.5L for the Treatment of Marionette
Lines: A Prospective, Open-Label, Post-Marketing Study.
Authors: Nicola Kefalas,
Sofia Ruiz Del Cueto, Carola de la Guardia, Graeme Kerson, Fernando
Urdiales Galvez, Alessandro
Gritti
- Perceptions surrounding aging and aesthetic medicine later
in life: Findings from a multi-country survey of adults aged 50 to
80 years with varying relationships with aesthetic
medicine. Authors: Shannon
Humphrey, MD; Jose Raul
Montes, MD; Nancy Etcoff,
PhD; Sasha Tyndale, MA; Stephanie Manson
Brown, MBBS, MRCS, MFPM
- Aesthetic Concerns Regarding Face and Body Appearance Among
Black Women: Results from A Large, Multigenerational Survey of
Aesthetically-Inclined Adults in the US. Jeanine Downie,
MD; Gaurav Bharti, MD; Charles Boyd, MD; Deirdre Hooper, MD; Amir
Moradi, MD; Heather
Woolery-Lloyd, MD; Elena
Dimitrijevic, PhD; Jorge Ng
Zheng, PharmD; Cheryl
Burgess, MD
- Aesthetic concerns regarding face and body appearance among
Hispanic and Latino Women: Results from Hispanic and Latino
female-identifying participants of a large survey of
aesthetically-inclined adults in the US. Authors:
Sabrina Fabi, MD; Gaurav Bharti, MD, FACS; Charles Boyd, MD; Elena
Dimitrijevic, PhD; Rosalyn
George, MD; Elizabeth
Houshmand, MD, FAAD; Alda
Karic, PharmD; Zakia Rahman,
MD, FAAD; Heather Woolery-Lloyd, MD,
FAAD
- Aesthetic concerns regarding face and body appearance among
Asian Women: Results from Asian female-identifying participants of
a large survey of aesthetically-inclined adults in the
US. Authors: Annie Chiu,
MD; Charles Boyd, MD; Cheryl Burgess, MD; Omer
Ibrahim, MD; Amir Moradi, MD;
Mona Sadeghpour, MD; Noëlle Sherber,
MD, FAAD; Neha Tandon, PhD;
Jorge Ng Zheng, PharmD, MBA, BCMAS;
Zakia Rahman, MD, FAAD
- Aesthetic concerns regarding face and body appearance among
women: Results from white female-identifying respondents of a large
survey of aesthetically inclined adults in the
US. Authors: Noelle
Sherber, Jeanine Downie,
Sabrina Fabi, Rosalyn George, Mona
Sadeghpour, Birgitte
Sondergaard, Alda Karic,
Deirdre Hooper
- Aesthetic concerns regarding face and body appearance among
men: Results from male-identifying participants of a large survey
of aesthetically-inclined adults in the U.S. Authors:
Omer Ibrahim, MD, FAAD; Elizabeth B. Houshmand, MD, FAAD; Noëlle
Sherber, MD, FAAD; Kamakshi Zeidler,
MD, FACS; Raza Ahmed, MD;
Jorge A. Ng Zheng, PharmD, MBA,
BCMAS; Terrence Keaney, MD,
FAAD
1 Allergan Aesthetics. Ethics social listening.
October 2022 – REF-102346
View original content to download
multimedia:https://www.prnewswire.com/news-releases/allergan-aesthetics-continues-to-champion-individuality-drive-innovation-and-lead-with-integrity-as-it-hosts-expert-led-symposia-at-amwc-2024-302095332.html
SOURCE AbbVie